논문번호 | 307 | ||
논문제목(영문) | Comparative treatment outcomes of a single long stent vs. overlapped short stents in acute myocardial infarction. | ||
국내외구분 | 국외 | SCI여부 | SCI(E) |
연구책임자역할 | 교신저자 | ||
주저자명 | Lee DH, Oh S | ||
교신저자명 | Kim IS, Jeong MH | ||
공동저자명 | Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y, Han JB | ||
게제년월일 | 2023-12-19 | ||
ISSN | 2297-055X | ||
Impact Factor | 3.6 | ||
학술지명 | Front Cardiovasc Med | ||
서지사항 | 0집 / 10권 / 0호, 페이지(1284396 - 1284396) | ||
요약초록문 (Abstract) 입력 |
Objectives: There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods. Methods: In total, 537 patients with AMI from a single tertiary center were categorized into two groups: (1) those who received an SLS (stent length ≥38 mm) (n = 254; 47.3%) and (2) those who received overlapped DSS (individual stent lengths <38 mm) (n = 283; 52.7%). The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCEs) within 1 year. Results: The mean age of participants was 65.4 years, and 75.0% were male. Patients receiving an SLS had a higher rate of serum creatinine level ≥1.5 mg/dl (16.3% vs. 8.9%, p = 0.009) but a lower rate of hypertension (46.8% vs. 55.8%, p = 0.038), lesser total stent length (38.26 ± 1.31 vs. 45.20 ± 9.25 mm, p < 0.001), total procedure time (41.40 ± 15.74 vs. 53.31 ± 21.75 min, p < 0.001) and total contrast volume (134.13 ± 30.72 vs. 160.57 ± 39.77 ml, p < 0.001) than in those receiving DSS. One-year MACCEs were comparable between the two groups before [hazard ratio (HR), 1.33; 95% confidence interval (CI), 0.80-2.24] and after adjusting for covariates (HR, 1.21; 95% CI, 0.67-2.19). Conclusions: Stenting with an SLS demonstrated similar outcomes compared to those achieved when using stenting with overlapped DSS in patients with AMI. Therefore, if the deliverability is acceptable, stenting with an SLS appears to be a safe and effective strategy for AMI treatment. |
||
파일 |
C307.pdf (2.5M) DATE : 2024-06-18 10:08:08 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved